Author(s): Wang L, Amphlett G, Lambert JM, Blttler W, Zhang W, Wang L, Amphlett G, Lambert JM, Blttler W, Zhang W, Wang L, Amphlett G, Lambert JM, Blttler W, Zhang W, Wang L, Amphlett G, Lambert JM, Blttler W, Zhang W
Abstract Share this page
Abstract PURPOSE: The aim of this study was to perform structural characterization of a recombinant monoclonal antibody (MAb), huN901, by electrospray time-of-flight mass spectrometry (ESI-TOFMS) using both "top-down" and "bottom-up" approaches. METHODS: In the top-down approach, the molecular masses of the deglycosylated huN901 and the light and heavy chains of the antibody were measured by direct infusion MS and liquid chromatography-mass spectrometry (LC-MS). In the bottom-up approach, trypsin and Asp-N protease were used to digest the separated, reduced and alkylated light and heavy chains followed by LC-MS analysis of the digests. RESULTS: The primary structure and post-translational modifications of huN901 were characterized by both top-down and bottom-up MS approaches. Modifications of N-terminal pyroglutamate formation, cleavage of C-terminal lysine, glycosylation, and deamidation were identified in the antibody heavy chain by both protein mass measurement and peptide mapping. No modifications were found in the complementarity determining regions (CDRs) of both chains. Both trypsin and Asp-N protease digestion had an average sequence recovery of 97\%, and generated complimentary mapping results with complete sequence recovery. CONCLUSIONS: ESI-TOFMS is a superior tool to characterize MAb and other complex protein pharmaceuticals.
This article was published in Pharm Res
and referenced in Immunotherapy: Open Access